SVFC Board Member: Myron Holubiak, Former Pres of Roche Labs
Myron Holubiak, Former President of Roche Labs
Great reading on our current board member.
Said Mr. Holubiak, "The decades of scientific research into regenerative medicine is now showing dramatic results and fulfilling the promise we all had hoped for.
"Dr. Victor's pioneering efforts in the advancement of the science and his innovations in the use of ultrasonic cavitation is now setting the standard for the harvest of autologous stromal vascular fractions that are demonstrating promise in clinical efficacy.
"I am pleased to join the board of IntelliCell. The company is committed to far reaching clinical research in the treatment of osteoarthritis, diabetic ulcers, bone and dermal conditions where regenerative processes are desperately needed.
"I look forward to participating in the growth of IntelliCell at such an exciting time."
PROFILE: Myron Holubiak, new president of Roche Labs
by Camilla Huk
NUTLEY, N.J. - There was only one regret I had in meeting with the new president of Roche Labs, Myron Holubiak, and that was that his parents didn't live to see this accomplished man in his plush offices in the executive suite on the pharmaceutical giant's Nutley campus.
Roche Labs, a subsidiary of Hoffmann La Roche, has revenues of over $2.8 billion and 3,500 employees. It is a long way from the tent in the displaced persons camp in Linz, Austria, where Mr. Holubiak was born in 1947.
Like many Ukrainian families, Myron's father, Alexander, who was the mayor of Horozhanka in the Ternopil region, fled the terrors of the Soviet occupation. He eventually came to the United States with his wife, Stephanie, and three children, Myron, and his sisters, Vera (who had polio and was fully paralyzed) and Ivanka. Having survived incarceration